Table 1 Clinical parameters of osteosarcoma patients enrolled in this study.

From: Doxorubicin-induced novel circRNA_0004674 facilitates osteosarcoma progression and chemoresistance by upregulating MCL1 through miR-142-5p

Pathological characteristics

Cases (n)

hsa_circ_0004674 expression

P value

High (40)

Low (40)

 

Gender

Male

47 (58.8%)

24 (60.0%)

23 (57.5%)

NS

Female

33 (41.2%)

16 (40.0%)

17 (42.5%)

 

Age

≥25

24 (30%)

11 (27.5%)

13 (32.5%)

NS

<25

56 (70%)

29 (72.5%)

27 (67.5%)

 

Location

   

NS

Distal of Femur

37 (46.3%)

18 (45.0%)

19 (47.5%)

 

Proximal of Tibia

27 (33.8%)

15 (37.5%)

12 (30.0%)

 

Other

16 (19.9%)

7 (17.5%)

9 (22.5%)

 

Enneking stage

   

<0.01

I + IIA

23 (28.8%)

6 (15.0%)

17 (42.5%)

 

IIB/III

57 (71.2%)

34 (85.0%)

23 (57.5%)

 

Chemoresistant

   

<0.01

Yes

32 (40%)

21 (52.5%)

11 (27.5%)

 

No

48 (60%)

19 (47.5%)

29 (72.5%)